Cargando…

Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer

Background: The aim of the study was to evaluate the role of different immunohistochemical and radiomics features in patients with small cell lung cancer (SCLC). Methods: Consecutive patients with histologically proven SCLC with limited (n = 47, 48%) or extensive disease (n = 51, 52%) treated with r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gkika, Eleni, Benndorf, Matthias, Oerther, Benedict, Mohammad, Farid, Beitinger, Susanne, Adebahr, Sonja, Carles, Montserrat, Schimek-Jasch, Tanja, Zamboglou, Constantinos, Frye, Björn C., Bamberg, Fabian, Waller, Cornelius F., Werner, Martin, Grosu, Anca L., Nestle, Ursula, Kayser, Gian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438800/ https://www.ncbi.nlm.nih.gov/pubmed/32903606 http://dx.doi.org/10.3389/fonc.2020.01161

Ejemplares similares

FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
por: Carles, Montserrat, et al.
Publicado: (2021)

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2018)

Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
por: Gkika, Eleni, et al.
Publicado: (2021)

Visualization of 4D multimodal imaging data and its applications in radiotherapy planning
por: Schlachter, Matthias, et al.
Publicado: (2017)

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
por: Carles, Montserrat, et al.
Publicado: (2021)

Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology
por: Gunashekar, Deepa Darshini, et al.
Publicado: (2022)

Simultaneous integrated protection: A new concept for high-precision radiation therapy
por: Brunner, Thomas B., et al.
Publicado: (2016)

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2017)

Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies
por: Spohn, Simon K.B., et al.
Publicado: (2021)

Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI—A Correlation Study With Whole Mount Histopathological Information as Reference
por: Kramer, Maria, et al.
Publicado: (2020)

Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer—A Secondary Analysis of the PET Plan Trial
por: Gkika, Eleni, et al.
Publicado: (2020)

User Interaction in Semi-Automatic Segmentation of Organs at Risk: a Case Study in Radiotherapy
por: Ramkumar, Anjana, et al.
Publicado: (2015)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
por: Gkika, Eleni, et al.
Publicado: (2023)

A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment
por: Duda, Dan, et al.
Publicado: (2023)

Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level
por: Oerther, Benedict, et al.
Publicado: (2021)

Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
por: van Timmeren, Janna E., et al.
Publicado: (2019)

Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
por: Spohn, Simon, et al.
Publicado: (2020)

(18)F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
por: Carles, Montserrat, et al.
Publicado: (2021)

Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer
por: Spohn, Simon K.B., et al.
Publicado: (2022)

Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland
por: Haehl, Erik, et al.
Publicado: (2022)

Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1)
por: Oehlke, Oliver, et al.
Publicado: (2016)

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2022)

Living systematic review and meta-analysis of the prostate MRI diagnostic test with Prostate Imaging Reporting and Data System (PI-RADS) assessment for the detection of prostate cancer: study protocol
por: Oerther, Benedict, et al.
Publicado: (2022)

Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference
por: Zamboglou, Constantinos, et al.
Publicado: (2019)

The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly
por: Haehl, Erik, et al.
Publicado: (2021)

Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in (68)GaPSMA-11 PET images of patients with primary prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2020)

PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
por: Zamboglou, Constantinos, et al.
Publicado: (2021)

Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters
por: Marinescu, Ioana M., et al.
Publicado: (2022)

The Value of Laboratory Parameters for Anemia, Renal Function, Systemic Inflammation and Nutritional Status as Predictors for Outcome in Elderly Patients with Head-and-Neck Cancers
por: Rühle, Alexander, et al.
Publicado: (2020)

Radiation-induced toxicities and outcomes after radiotherapy are independent of patient age in elderly salivary gland cancer patients: results from a matched-pair analysis of a rare disease
por: Rühle, Alexander, et al.
Publicado: (2020)

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients
por: Rühle, Alexander, et al.
Publicado: (2022)

Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy?
por: Rühle, Alexander, et al.
Publicado: (2021)

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis
por: Bettinger, Dominik, et al.
Publicado: (2018)

Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition
por: Sachpazidis, Ilias, et al.
Publicado: (2020)

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
por: Spohn, Simon K. B., et al.
Publicado: (2023)

Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference
por: Spohn, Simon K. B., et al.
Publicado: (2021)

Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies
por: Arbuznikova, Daria, et al.
Publicado: (2023)

Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses
por: Wolf, Jule, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_565i1hinkaoresiv1mc4e2km2l